Literature DB >> 22097919

Expression of oxytocin receptor in diabetic rat penis.

M Li1, T Wang, S Guo, K Rao, J Liu, Z Ye.   

Abstract

Oxytocin receptor (OTR) expressed in the rat penis and mediated the contractility of the corpus cavernosum smooth muscle both in vitro and in vivo, and OTR could maintain penile detumescence; however, the expression of OTR in diabetic rat penis remains unknown. In the present study, we investigated the expression of OTR in diabetic rat penis. The experimental rats were randomly divided into control group and STZ-diabetic rats group. The expressions of mRNA and protein were examined by real-time quantitative PCR, Western blotting and immunohistochemistry respectively. Erectile function was evaluated by measuring intracavernous pressure following electrostimulation of the cavernous nerves. mRNA and protein expression of OTR significantly increased in diabetic rats group compared with the control group. Erectile function of diabetic rats group significantly decreased compared with the control group. Our data showed that the expression of OTR significantly increased in diabetic rats group and OTR may involve in the development of diabetic erectile dysfunction.
© 2011 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22097919     DOI: 10.1111/j.1439-0272.2011.01255.x

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  2 in total

1.  Reduced corporal fibrosis to protect erectile function by inhibiting the Rho-kinase/LIM-kinase/cofilin pathway in the aged transgenic rat harboring human tissue kallikrein 1.

Authors:  Kai Cui; Yang Luan; Tao Wang; Li Zhuan; Ke Rao; Shao-Gang Wang; Zhang-Qun Ye; Ji-Hong Liu; Dao-Wen Wang
Journal:  Asian J Androl       Date:  2017 Jan-Feb       Impact factor: 3.285

2.  Examination of the immunohistochemical localization and gene expression by RT-PCR of the oxytocin receptor in diabetic and non-diabetic mouse testis.

Authors:  Ayşe Aydoğan; Seyit Ali Bingöl
Journal:  Iran J Basic Med Sci       Date:  2018-07       Impact factor: 2.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.